Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
Rangering i aksjer #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$1.17K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel PhaseRx, Inc. (PZRXQ)

Kategori

Pris PZRXQ pris med markedsverdi på B
PhaseRx, Inc. PhaseRx, Inc.
PZRXQ
$0.0001
Markedsverdi av PhaseRx, Inc.(PZRXQ)
Markedsverdi: $1.17K
Per August 2026 har PhaseRx, Inc. en markedsverdi på $1.17K. Dette gjør PhaseRx, Inc. til det 42474th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for PhaseRx, Inc. fra 2016 til 2026
PZRXQ sammenlignet med topp 5 mest populære stocks
Pris på PZRXQ Eiendel B Markedsverdi for B Resultater
PhaseRx, Inc. PhaseRx, Inc.
$464,169 $1.17K
$5.426T +464,168,840,447.48%
PhaseRx, Inc. PhaseRx, Inc.
$378,617 $1.17K
$4.426T +378,617,171,037.73%
PhaseRx, Inc. PhaseRx, Inc.
$355,751 $1.17K
$4.159T +355,751,159,202.91%
PhaseRx, Inc. PhaseRx, Inc.
$313,309 $1.17K
$3.663T +313,308,663,886.31%
PhaseRx, Inc. PhaseRx, Inc.
$247,381 $1.17K
$2.892T +247,381,085,150.73%